Effect of Pulse Steroid Therapy on Visual Acuity and Fundus Picture in Cases of Vogt Koyanagi Harada Syndrome in Yemen: Case Series Study
DOI:
https://doi.org/10.65693/masj.2023.v2i1.22Keywords:
Vogt Koyanagi Harada syndrome, pulse steroid therapy, visual outcome, Yemen.Abstract
Vogt-Koyanagi-Harada syndrome (VKHS) is a rare systemic disease with severe bilateral panuveitis associated with cutaneous, neurological, and auditory abnormalities. This study aims to evaluate the effect of pulse steroid therapy on the visual acuity and fundus picture of cases of VKHS presented at Maghrabi Eye Hospital in Yemen. Method: This retrospective case series was followed up for three years between (2007-2010) for three female patients who presented by bilateral hand motion and complained with headache, neck stiffness and difficulty in hearing. Results: After pulse steroid therapy, the best corrected visual was improved with resolution of optic disc swelling and serous retinal detachment detected by optical coherence tomography (OCT). One eye had complication as sunset glow and suprarational fibrosis. Conclusion: VKHS is uncommon disease in Yemen and affects mostly female. Urgent intervention with pulse steroid therapy and systemic corticosteroid and early diagnosis decrease the complications and improve the visual acuity.
References
Johal B, Johal H, Lukaris AJUBCMJ. The clinical presentation and diagnosis of Vogt-Koyanagi-Harada syndrome. 2015;6:20-2.
2. Herbort CP, Jr., Tugal-Tutkun I, Abu-El-Asrar A, Gupta A, Takeuchi M, Fardeau C, et al. Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review. Eye (Lond). 2022;36(1):29-43.
3. Sen HNJW, Fundamentals NsU, Practice C. Vogt-Koyanagi-Harada Syndrome. 2021:296.
4. Herbort CP, Mochizuki MJIO. Vogt–Koyanagi–Harada disease. Springer; 2007. p. 63-5.
5. Baltmr A, Lightman S, Tomkins-Netzer OJCO. Vogt–Koyanagi–Harada syndrome–current perspectives. 2016:2345-61.
6. Urzua CA, Herbort CP, Jr., Takeuchi M, Schlaen A, Concha-Del-Rio LE, Usui Y, et al. Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review. J Ophthalmic Inflamm Infect. 2022;12(1):17.
7. Accorinti M, Saturno MC, Iannetti L, Manni P, Mastromarino D, Pirraglia MP. Treatment and Prognosis of Vogt-Koyanagi-Harada Disease: Real-Life Experience in Long-Term Follow-Up. J Clin Med. 2022;11(13).
8. Lavezzo MM, Sakata VM, Morita C, Rodriguez EEC, Abdallah SF, da Silva FT, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. 2016;11:1-21.
9. Zhang Q, Fan X, Tian M, Han HJBn. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome. 2020;21(1):1-5.
10. Rao NA, Moorthy RS, Inomata HJIoc. Vogt-Koyanagi-Harada syndrome. 1995;35(2):69-86.
11. Chan C-C, Palestine AG, Kuwabara T, Nussenblatt RBJAjoo. Immunopathologic study of Vogt-Koyanagi-Harada syndrome. 1988;105(6):607-11.
12. Nakayama M, Keino H, Watanabe T, Okada AA. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. Br J Ophthalmol. 2019;103(2):274-8.
13. Herbort CP, Jr., Abu El Asrar AM, Takeuchi M, Pavesio CE, Couto C, Hedayatfar A, et al. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease. Int Ophthalmol. 2019;39(6):1419-25.
14. Chang JH-M, Wakefield DJOi, inflammation. Uveitis: a global perspective. 2002;10(4):263-79.
15. Hosseini SM, Dourandish M, Mazouchi M. Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome. Journal of ophthalmic & vision research. 2020;15(1):99-103.
16. Dias NdC, Ventura CV. Vogt-Koyanagi-Harada syndrome: a discussion about resistance to corticotherapy. Revista Brasileira de Oftalmologia. 2021;80(3).
17. Yamanaka E, Ohguro N, Yamamoto S, Nakagawa Y, Imoto Y, Tano Y. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography. American journal of ophthalmology. 2002;134(3):454-6.
18. Badsha H, Edwards CJ. Intravenous pulses of methylprednisolone for systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 2003;32(6):370-7.
19. Miyanaga M, Kawaguchi T, Shimizu K, Miyata K, Mochizuki M. Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt–Koyanagi–Harada disease. International Ophthalmology. 2007;27(2):183-8.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal which means that all content is freely available without charge to the user or their institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, provided the original work is properly cited. All articles are licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
